Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6043350B2 - 2-Azaerythrinane derivative - Google Patents
[go: Go Back, main page]

JPS6043350B2 - 2-Azaerythrinane derivative - Google Patents

2-Azaerythrinane derivative

Info

Publication number
JPS6043350B2
JPS6043350B2 JP55009175A JP917580A JPS6043350B2 JP S6043350 B2 JPS6043350 B2 JP S6043350B2 JP 55009175 A JP55009175 A JP 55009175A JP 917580 A JP917580 A JP 917580A JP S6043350 B2 JPS6043350 B2 JP S6043350B2
Authority
JP
Japan
Prior art keywords
residue
azaerythrinane
oxo
formulas
tables
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55009175A
Other languages
Japanese (ja)
Other versions
JPS56108789A (en
Inventor
博 村井
進午 松村
岩男 森田
光洋 前原
憲二 数野
宏 榎本
喜代史 木村
豊 木村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP55009175A priority Critical patent/JPS6043350B2/en
Publication of JPS56108789A publication Critical patent/JPS56108789A/en
Publication of JPS6043350B2 publication Critical patent/JPS6043350B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、次の一般式〔1〕で表わされる8一オキソー
2−アザエリスリナン誘導体および酸付加塩に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an 8-oxo-2-azaerythrinane derivative and an acid addition salt represented by the following general formula [1].

ただし、YははO又は1を表わす。However, Y represents O or 1.

)を表わし、bは1又は2を表わし、R1及びR2は同
一又は異なつて水素、低級アルコキシ、ハロゲン又は水
素基を表わし、R3は水素、低級アルキル、低級アルコ
キシ、ハロゲン、ニトロ基、又は水酸基を表わす。但し
R2とR3は合してテトラメチレンを表わしても良い。
R4は水素、低級アルキル、低級アルコキシ
/R5カルボニル、−CH2CH=C5
R6(ここにR5、R6は同一又は異なつて、水素、低
級アルキル又はフェニルを表わす。
), b represents 1 or 2, R1 and R2 are the same or different and represent hydrogen, lower alkoxy, halogen or a hydrogen group, R3 represents hydrogen, lower alkyl, lower alkoxy, halogen, nitro group, or hydroxyl group. represent. However, R2 and R3 may collectively represent tetramethylene.
R4 is hydrogen, lower alkyl, lower alkoxy
/R5 carbonyl, -CH2CH=C5
R6 (here, R5 and R6 are the same or different and represent hydrogen, lower alkyl or phenyl).

)、(ここにmは1、2又は3を表わす。), (where m represents 1, 2 or 3.

)、一(CH2)m−ーーCO−<′C)) にこに
mは1、2又は3を表わし、R7は水素、ハロゲン、低
級アルキル又は低級アルコキシを表わす。
), (CH2)m--CO-<'C)) m represents 1, 2 or 3, and R7 represents hydrogen, halogen, lower alkyl or lower alkoxy.

)、一(CH2)In一店H−(7S\ (ここにmは
L2又は3を表わす。)、 ゞH2」卜 』2K8(こ
こにR8は水素又は低級アルキルを表わす。)、ーー般
式〔■〕(式中R9=ベンジル、フェネチル、メチル、
又はエトキシカルボニル基、RlO=エチル基、n=1
、2)で示される4−ピペリドン化合物と一般式〔■〕
(式中R1、R2、R3、Y及び=は前記と同じ)で示
されるアミン類とを不活性な有機溶媒中で加熱縮合し、
縮合物を単離するか又は単離することなく、酸性条件下
で加熱して閉環せしめることにより得ることができる。
加熱縮合に使用する不活性な有機溶媒としてはベンゼン
、トルエン、キシレン、DMFlジオキサン、セロソル
ブ、ジグライム等の高沸点溶媒を使用し、水分除去器を
付して加熱還流するのが好ましい。次に酸性条件下ての
閉環反応は硫酸、臭化水素酸、塩酸、リン酸等の鉱酸類
あるいはギ酸、p−トルエンスルホン酸、トリクロロ酢
酸、トリプル又は 一℃H2一凸−N<7−ーー゛ を
表わす。
), 1(CH2)In1 shopH-(7S\ (here m represents L2 or 3), ゞH2'' 2K8 (here R8 represents hydrogen or lower alkyl), - general formula [■] (In the formula, R9 = benzyl, phenethyl, methyl,
or ethoxycarbonyl group, RlO=ethyl group, n=1
, 2) and the general formula [■]
(wherein R1, R2, R3, Y and = are the same as above) are heated and condensed in an inert organic solvent,
It can be obtained by isolating the condensate or without isolating it by heating under acidic conditions to cause ring closure.
As the inert organic solvent used in the thermal condensation, it is preferable to use a high boiling point solvent such as benzene, toluene, xylene, DMFl dioxane, cellosolve, diglyme, etc., and heat it to reflux with a water remover attached. Next, the ring-closing reaction under acidic conditions is carried out using mineral acids such as sulfuric acid, hydrobromic acid, hydrochloric acid, phosphoric acid, or formic acid, p-toluenesulfonic acid, trichloroacetic acid, triple or 1℃H2 monoconvex-N<7--゛ represents.

また、二部は不飽和結合か又は飽和結合を表わす。本発
明者らは数多くのアザエリスリナン誘導体を合成し、そ
の薬理作用を鋭意研究中、幸運にもこれら化合物の激越
な鎮痛作用を見出し本発明を完成した。
Moreover, the second part represents an unsaturated bond or a saturated bond. The present inventors have synthesized a number of azaerythrinane derivatives, and while intensively researching their pharmacological effects, fortunately discovered the remarkable analgesic effect of these compounds and completed the present invention.

本発明化合物は、文献未載の新規化合物で中枢神経抑制
作用を有し、医薬品として有用である。本発明化合物は
種々の方法により製造することができるが、オロ酢酸等
の有機酸類か又はポリリン酸 (PPA)、ポリリン酸エステル(PPE)、五酸化リ
ン、酸性イオン交換樹脂等を単独又は水溶液が有機溶媒
中で加熱することにより行なわれる。
The compound of the present invention is a novel compound that has not been described in any literature, has a central nervous system depressing effect, and is useful as a pharmaceutical. The compound of the present invention can be produced by various methods, but organic acids such as oroacetic acid, polyphosphoric acid (PPA), polyphosphoric acid ester (PPE), phosphorus pentoxide, acidic ion exchange resin, etc. can be used alone or in an aqueous solution. It is carried out by heating in an organic solvent.

反応温度は30〜250℃の範囲内で、好ましくは80
〜160゜Cで行なうのがよく、反応時間は3紛から数
時間を要して閉環反応が達成される。一般式〔■〕のR
9=CO2C2ll5を原料として用いた場合は酸性条
件下での反応中に1部加水分解を受けることもあり、一
般式〔1〕のR4=CO2C2H5とR4=Hの混合物
として生成するため、中性物質と塩基性物質に分けて単
離しなければならない。ただし、どちらか一方を所望す
るときは酸性条件の選択により可能である。一般式〔1
〕の合成に使用した化合物〔■〕は下記に示す、エチル
4−ピペリドンー3−カルボキシレート類を原料にして
3位に一(CH2)NCO2RlO基を導入後加水分解
、脱炭酸してケトカルボン酸とし、エステル化すると得
ることがでる。
The reaction temperature is within the range of 30 to 250°C, preferably 80°C.
It is best to carry out the reaction at a temperature of -160°C, and the reaction time ranges from 3 to several hours to achieve the ring-closing reaction. R of general formula [■]
When 9=CO2C2ll5 is used as a raw material, it may undergo partial hydrolysis during the reaction under acidic conditions, and is produced as a mixture of R4=CO2C2H5 and R4=H in general formula [1], so it is neutral. Substances and basic substances must be separated and isolated. However, if either one is desired, it is possible by selecting acidic conditions. General formula [1
] The compound [■] used in the synthesis of ethyl 4-piperidone-3-carboxylate shown below was used as a raw material, and after introducing a mono(CH2)NCO2RlO group at the 3-position, it was hydrolyzed and decarboxylated to form a ketocarboxylic acid. , can be obtained by esterification.

R9=エトキシカルボニル体は〔■〕式のR9=ベンジ
ル体をエチルクロロホルメートと反応することにより容
易に脱ベンジル化して得られる。一般式〔1〕中のR4
がR9以外の置換基については、前記閉環反応により合
成した一般式〔1〕中のR4=エトキシカルボニルとR
4=ベンジルを用い、前者では酸又はアルカリ条件下で
加水分解して〔1〕R4=H体とし、後者のベンジル基
は加水素分解により還元的に脱離して、〔1′)R4=
H体とするか、又はブロムシアンやクロロホルメート類
たとえばエチルクロロホルメートを反応せしめて前述〔
1′)R4=エトキシカルボニル体とし、同様に加水分
解して〔1〕R4=H体を得、次いでこの〔1′)R4
=H体を用いて所望の置換基を導入すればよい、脱エト
キシカルボニル化は好ましくは酸性条件下で、特に鉱酸
中で加熱還流すると容易に〔1,1R4=H体を得るこ
とができる。〔1′1R4=Hのアルキル化は一般的な
アルキル化により容易に行なえる。
The R9=ethoxycarbonyl compound can be easily obtained by debenzylating the R9=benzyl compound of the formula [■] by reacting it with ethyl chloroformate. R4 in general formula [1]
For substituents other than R9, R4=ethoxycarbonyl and R in the general formula [1] synthesized by the ring-closing reaction
Using 4=benzyl, the former is hydrolyzed under acidic or alkaline conditions to form [1] R4=H form, and the latter benzyl group is reductively eliminated by hydrolysis to form [1') R4=
The above-mentioned [
1') R4 = ethoxycarbonyl body, hydrolyzed in the same manner to obtain [1] R4 = H body, and then this [1') R4
Desired substituents may be introduced using the =H form. Deethoxycarbonylation is preferably carried out under acidic conditions, particularly when heated under reflux in a mineral acid [1,1R4=H form can be easily obtained] . [Alkylation of 1'1R4=H can be easily carried out by general alkylation.

たとえば、脱酸剤の存在下にアルキルハライド類や反応
性エステル類を反応せしめるか、アルデヒド類を還元的
にアルキル化する方法が用いられる。アラルキル化やア
リル化も同様にして行なえる。〔1′)R4=2−ベン
ゾイルエチル体はアセトフェノンとホルマリンとを用い
るMannich反応により、〔1)R4=3−オキシ
ー3−フェニルプロピル体はMannich反応で得た
2−ベンゾイルエチル体を還元して得られる。〔1〕R
4=ブチロフエノン類は3−ベンゾイルプロピルハライ
ド類をケタール化してカルボニル基を保護して〔1〕R
4=H体と反応せしめ、次いで加水分解により脱ケター
ル化して得られる。〔1〕R1、R2=H..R3=ニ
トロ化合物は〔1)R1、R2、R3、R4=H体を一
般的なニトロ化条件でニトロ化すれば好収率で得ること
がてきる。〔1〕式中 2〔一 と
体をアシル化およびアリール
化すれば容易に得ることができる。
For example, a method is used in which alkyl halides or reactive esters are reacted in the presence of a deoxidizing agent, or aldehydes are reductively alkylated. Aralkylation and allylation can be carried out in the same manner. [1') R4 = 2-benzoylethyl form is obtained by Mannich reaction using acetophenone and formalin, [1) R4 = 3-oxy-3-phenylpropyl form is obtained by reducing the 2-benzoylethyl form obtained by Mannich reaction. can get. [1] R
4=Butyrophenones are produced by ketalizing 3-benzoylpropyl halides to protect the carbonyl group [1]R
It is obtained by reacting with 4=H form and then deketalizing by hydrolysis. [1] R1, R2=H. .. The R3=nitro compound can be obtained in good yield by nitrating the R1, R2, R3, R4=H form under general nitration conditions. [1] In the formula 2 [one and
It can be easily obtained by acylating and arylating the compound.

又、 111Y=ー占?体は直鎖閉環反応によつても得
ることができるが、 体をメチル化する
ことも容易である。
Also, 111Y = - fortune telling? The body can also be obtained by a linear ring closure reaction, but it is also easy to methylate the body.

閉環反応後に〔1〕R4=ベンジル基から他の置換基に
変換する方法としては、所望する置換基のハライド類や
その活性エステル類と反応せしめて四級塩とし、次いで
還元的に脱ベンジル化するか、アルカリ溶液中でチオフ
ェノールを用いて脱ベンジル化する方法がある。〔1〕
式中R1、R2、R3が水酸基の化合物は対応するーメ
トキシ体を脱メチル化することにより得られる。
After the ring-closing reaction, [1] A method for converting R4 = benzyl group into another substituent is to react the desired substituent with a halide or its active ester to form a quaternary salt, and then reductive debenzylation. Alternatively, there is a method of debenzylation using thiophenol in an alkaline solution. [1]
A compound in which R1, R2, and R3 are hydroxyl groups can be obtained by demethylating the corresponding -methoxy compound.

メトキシ基の脱メチル化は一般的な方法、たとえば臭化
水素酸と共に加熱すれば好収率で脱メチル化できる。脱
メチル化条件下でR4の置換基が変化を受ける場合は、
下記に示す一般式〔■〕(式中Y..nは前記と同じ)
のメトキシ基を脱メチル化して〔■〕とし、次いで〔■
〕を前述のアルキル化条件でN位をR4で置換して〔■
〕とする。
Demethylation of the methoxy group can be carried out in a good yield by a conventional method, for example, by heating with hydrobromic acid. If the substituent of R4 undergoes a change under demethylation conditions,
General formula [■] shown below (in the formula, Y...n is the same as above)
The methoxy group of is demethylated to give [■], and then [■
] was substituted with R4 at the N-position under the above alkylation conditions to produce [■
].

但し、同時に起るO−アルキル化を防ぐため脱酸剤を使
用する時は炭酸塩を用いることが望ましい。脱メチル化
条件で変化を受けない置換基の場合でも同様の方法で〔
■〕を得ることができる。一般式〔1〕で示される化合
物は2個の不斉炭素(C−5とC−6位)を有している
が、エリスリナン骨格の場合閉環反応時にA/B間の環
結合がCis結合のもののみが生成することをA.MO
ndOn等〔Ber.、?、46(1965)〕はその
骨格合成において証明している。
However, in order to prevent simultaneous O-alkylation, when using a deoxidizing agent, it is preferable to use a carbonate. A similar method can be used for substituents that do not undergo changes under demethylation conditions.
■] can be obtained. The compound represented by the general formula [1] has two asymmetric carbons (C-5 and C-6 positions), but in the case of the erythrinane skeleton, the ring bond between A and B is a Cis bond during the ring-closing reaction. A. M.O.
ndOn et al. [Ber. ,? , 46 (1965)] demonstrated this in its skeleton synthesis.

そのため同様の反応により生成する化合物〔1〕はA/
Bcisのラセミ体である。代表的な鎮痛剤であるモル
ヒネは左旋性であり、モルヒネ様の合成鎮痛剤も一般に
左旋性の方が活性である。いずれにしてもラセミ体を光
学分割して光学活性な化合物を得れば、どちらか一方が
活性でラセミ体より強くなるのが一般的である。一般式
〔1〕で示される化合物についても光学活性な誘導体を
得ることがでできる。
Therefore, the compound [1] produced by the same reaction is A/
It is a racemic form of Bcis. Morphine, a typical analgesic, is levorotatory, and morphine-like synthetic analgesics are generally more active when they are levorotatory. In any case, if a racemic compound is optically resolved to obtain an optically active compound, one of the compounds will generally be more active and stronger than the racemic compound. Optically active derivatives of the compound represented by the general formula [1] can also be obtained.

光学分割は常法通り光学活性な有機酸類を用いてその塩
類と分別結晶すれは容易にできる。光学分割は〔1〕式
の各々についても可能であるが、〔1〕式中R4=Hの
化合物について分割した後、所望の置換基をR4位に導
入する方法によつても得ることができる。以上のように
して得た一般式〔1〕で示される化合物は塩酸又は生理
学的に許容しうる酸によつて結晶性酸付加塩に変えるこ
とができる。
Optical resolution can be easily carried out using optically active organic acids and their salts and fractional crystallization as usual. Optical resolution is possible for each of the formulas [1], but it can also be obtained by a method in which a desired substituent is introduced into the R4 position after resolution of the compound where R4=H in the formula [1] . The compound represented by the general formula [1] obtained as described above can be converted into a crystalline acid addition salt with hydrochloric acid or a physiologically acceptable acid.

以下に本発明化合物の鎮痛作用を述べる。The analgesic effect of the compounds of the present invention will be described below.

KOstar等の方法〔Fed.PrOc.、坦、41
2(1959)を参照〕に準じてDd系雄性マウス(体
重25〜32y)1群6匹として用い、0.6%酢酸を
10mtIk9腹腔内投与した際に生じるWrithi
ng数を測定し、対照群に対する抑制を指標とした。
The method of KOstar et al. [Fed. PrOc. , Tan, 41
2 (1959)], Dd strain male mice (body weight 25-32 years) were used in groups of 6, and 0.6% acetic acid was administered intraperitoneally to 10mtIk9.
The number of ng was measured, and inhibition relative to the control group was used as an index.

また、体重23〜30ダのDd系雄性マウスを用い、一
群4匹としノて各被検薬物投与(1.p.)後24時間
における死亡率よりWeil氏法によつてLD5O値を
算出した。これらの結果を表1に示す。これらにより、
本発明化合物の優れた薬理効果が明らかである。
In addition, the LD5O value was calculated by Weil's method from the mortality rate 24 hours after administration of each test drug (1.p.) using male Dd mice weighing 23 to 30 da, with 4 mice per group. . These results are shown in Table 1. With these,
The excellent pharmacological effects of the compounds of the present invention are obvious.

本発明化合物の一部を表2に示した。Table 2 shows some of the compounds of the present invention.

なお、第2表中の化合物は一般式〔1〕における記号を
もつて表おし、:は特に明記してある場合を除いて不飽
和結合を意味し、nは、化合物番号35〜42の8化合
物については2、他はいずれも1である。
In addition, the compounds in Table 2 are expressed with the symbols in general formula [1], : means an unsaturated bond unless otherwise specified, and n is the compound number 35 to 42. It is 2 for 8 compounds and 1 for all others.

また、化合物番号167以下170までは、いずれも光
学活性体である。以下に本発明化合物の製造に関する実
施例を掲げる。
Further, all of compound numbers 167 to 170 are optically active compounds. Examples related to the production of the compounds of the present invention are listed below.

実施例1 2−ベンジルー8−オキソー2−アザエリスリナン(化
合物番号1)エチル1−ベンジルー4−ピペリドンー3
−アセテート2.75yを乾燥したベンゼン20m1に
溶解し、これにエチルクロロホルメート1.6gを加え
て2時間加熱還流する。
Example 1 2-benzy-8-oxo-2-azaerythrinane (compound number 1) ethyl 1-benzy-4-piperidone-3
- 2.75y of acetate is dissolved in 20ml of dry benzene, 1.6g of ethyl chloroformate is added thereto, and the mixture is heated under reflux for 2 hours.

冷後反応液を水洗、乾燥してベンゼンを留去し、残留物
を減圧蒸留するとエチル1−エトキシカルボニルー4−
ピペリドンー3−アセテートが得られる。B.p.l4
4〜80.2噸Hg得量=1.70y(75.6%)取
ν以+TCm−1:2980、1700(1720に肩
)、1475、143臥1380、134F3s130
&1276、1237、118011145.111\
102α760エチル1−ベンジルー4−ピペリドンー
3−アセテート19.3yと等モルのβ−フェネチルア
ミン8.5VをDean&Starkセパレーターを付
したナス型フラスコに入れ、これにトルエン150mL
を加えて托時間加熱還流する。
After cooling, the reaction solution was washed with water and dried to remove benzene, and the residue was distilled under reduced pressure to obtain ethyl 1-ethoxycarbonyl-4-
Piperidone-3-acetate is obtained. B. p. l4
4 to 80.2 tons Hg gain = 1.70y (75.6%) + TCm-1: 2980, 1700 (shoulder to 1720), 1475, 143゜1380, 134F3s130
&1276, 1237, 118011145.111\
102α760 Ethyl 1-benzyl-4-piperidone-3-acetate 19.3y and 8.5V of β-phenethylamine are placed in an eggplant-shaped flask equipped with a Dean & Stark separator, and 150 mL of toluene is added to the flask.
Add and heat to reflux for an hour.

この間セパレーターで留出してくるH2Oを除去する。
反応液を濃縮し、残留物をさらに150〜60゜Cの油
浴上で3時間加熱する。冷後反応混合物にポリリン酸(
PPA)200yを加えて150′Cの油浴上で3時間
加熱攪拌する。
During this time, H2O distilled out is removed using a separator.
The reaction solution is concentrated and the residue is further heated on an oil bath at 150-60°C for 3 hours. After cooling, polyphosphoric acid (
Add 200y of PPA) and heat and stir on an oil bath at 150'C for 3 hours.

冷後反応液を1.51の氷水中に注ぎ、炭酸カリウムを
加えて中和し、遊離する油状物をCHCl3で抽出、水
洗して乾燥後CHCl3を留去して、残留物にEt2O
を加えて加熱溶解し、不純物を枦去、沖液のEt2O溶
液を濃縮して残留物をHCl塩として結晶化エタノール
から再結晶。HCl塩得量=19.0q..mp268
゜C(Dec.)IRvl:綱c!n−1:1700(
5員環ラクタム)実施例28−オキソー2−フェネチル
ー2−アザエリスリナン(化合物番号13)水分除去器
を付した二径のナス型フラスコにエチル1−フェネチル
ー4−ピペリドンー3−アセテート5.8yと等モルの
β−フェネチルアミン2.49を入れ、50m1のトル
エンを加えて托時間加熱還流する。
After cooling, the reaction solution was poured into 1.51 g of ice water, neutralized by adding potassium carbonate, and the liberated oil was extracted with CHCl3, washed with water, dried, and CHCl3 was distilled off, and the residue was mixed with Et2O.
Add and heat to dissolve, remove impurities, concentrate the Et2O solution of Oki liquid, and crystallize the residue as HCl salt. Recrystallize from ethanol. HCl salt yield = 19.0q. .. mp268
゜C (Dec.) IRvl: Rope c! n-1:1700(
5-membered ring lactam) Example 28-Oxo-2-phenethyl-2-azaerythrinane (Compound No. 13) Equimolar amount of 5.8y of ethyl 1-phenethyl-4-piperidone-3-acetate was placed in a two-diameter eggplant-shaped flask equipped with a water remover. 2.49 of β-phenethylamine was added, 50 ml of toluene was added, and the mixture was heated under reflux for an hour.

この間セパレーターで留出する水分を除去する。反応液
を濃縮し、残留物を150〜60℃の油浴上でさらに3
時間加熱する。冷後反応混合物にポリリン酸70yを加
え140℃の油浴上で6時間加熱攪拌する。冷後反応液
を300n1の氷水に注ぎ、K2CO3で中和して遊離
してくる油状物をCHCl3で抽出、水洗して乾燥しC
HCl3を留去する。残留物にEt2Oを加えて不溶物
を戸去し、Et2O溶液を濃縮する。残留物4.5yを
得、塩酸塩にして結晶化、枦取し、EtOHから再結晶
、得量=2.6fmp290℃(Dec.)釈」(→d
−1:1680(5員環ラクタム)実施例32−メチル
ー?−オキソー2−アザーB−ホモエリスリナン(化合
物番号35)エチルβ−(1−メチルー4−ピペリドン
ー3一)プロピオネー目5.0yと等モルのβ−フェネ
チルアミン8.9VをDean&Starkセパレータ
ーを付したナス型フラスコ中に入れ、これにトルエン1
50m1を加えて■時間加熱還流する。
During this time, distilled water is removed using a separator. The reaction solution was concentrated, and the residue was further heated on an oil bath at 150-60°C for 3
Heat for an hour. After cooling, 70y of polyphosphoric acid was added to the reaction mixture, and the mixture was heated and stirred on a 140°C oil bath for 6 hours. After cooling, the reaction solution was poured into 300n1 of ice water, neutralized with K2CO3, and the liberated oil was extracted with CHCl3, washed with water, dried, and concentrated with C.
HCl3 is distilled off. Et2O is added to the residue to remove insoluble matter, and the Et2O solution is concentrated. 4.5y of residue was obtained, crystallized as hydrochloride, collected, recrystallized from EtOH, yield = 2.6fmp, diluted at 290°C (Dec.).
-1:1680 (5-membered ring lactam) Example 32-methyl? -Oxo 2-Ather B-Homoerythrinane (Compound No. 35) Ethyl β-(1-methyl-4-piperidone-31) propionate 5.0y and 8.9V of β-phenethylamine in an equal molar amount were placed in an eggplant-shaped flask equipped with a Dean & Stark separator. Put it inside and add 1 toluene to it.
Add 50 ml of the mixture and heat under reflux for 1 hour.

この間セパレーターで留出するH2Oを除去する。反応
液を濃縮し、残留物をさらに150〜60℃の油浴上で
3時間加熱する。冷後反応混合物にポリリン酸“(PP
A)200yを加えて140〜50℃の油浴上で5時間
加熱攪拌する。冷後反応液を1.5eの氷水中に注ぎ、
炭酸カリウムを加えて中和し、遊離する油状物をCHC
l3で抽出、水洗して乾燥後CHCl3を留去して残留
物にEt2Oを加えて加熱溶解し不溶物を枦去し、炉液
を濃縮して残留物を硫酸塩として結晶化、MeOHから
再結晶。硫酸塩得量=16.0ymp276eC(De
c.)IRp!:■d−1:1640(6員環ラクタム
)実施例48−オキソー2−アザエリスリナン(化合物
番号43)(a)1−ベンジルー8−オキソー2−アザ
エリスリナン塩酸塩33.5yを30%エタノール水溶
液300m1に溶解し、10%Pd−C5.Oyを触媒
にして常圧用接触還元装置で接触還元する。
During this time, distilled H2O is removed using a separator. The reaction solution is concentrated and the residue is further heated on an oil bath at 150-60°C for 3 hours. After cooling, polyphosphoric acid (PP) was added to the reaction mixture.
A) Add 200y and heat and stir on an oil bath at 140 to 50°C for 5 hours. After cooling, the reaction solution was poured into 1.5e ice water.
Neutralize by adding potassium carbonate and convert the liberated oil to CHC.
After extraction with 13 liters of water, washing with water and drying, CHCl3 was distilled off, Et2O was added to the residue and dissolved by heating to remove insoluble matter. crystal. Sulfate yield = 16.0ymp276eC (De
c. )IRp! :■d-1:1640 (6-membered ring lactam) Example 48-oxo-2-azaerythrinane (compound number 43) (a) 33.5y of 1-benzy-8-oxo2-azaerythrinane hydrochloride was dissolved in 300ml of 30% aqueous ethanol solution. Dissolve 10% Pd-C5. Catalytic reduction is carried out in a normal pressure catalytic reduction apparatus using Oy as a catalyst.

還元後触媒を枦去して沖液を減圧下に濃縮し、残査の塩
酸塩(Mp24O〜2℃)を水に溶解して炭酸カリウム
て中和、食塩で塩析し、遊離する塩基をCHCl3で抽
出、水洗して乾燥後CHCl3を留去すノ る。残留物
をEt2Oで結晶化して淵取する。得量=22.0f,
.mp119〜21てCIRv?■Cm−1:3300
(〉NH)、1670(5員環ラ クタム)(b) 一
方、エチル8−オキソー2−アザエリスリナンー2−カ
ルボキシレート18.0yを濃塩酸100m1中で10
時間加熱還流して、減圧下に濃縮し、残査をEtOHか
ら再結晶すれば塩酸塩13.0y(Mp24O〜2℃)
を得ることができる。
After reduction, the catalyst was removed and the Oki liquid was concentrated under reduced pressure. The remaining hydrochloride salt (Mp24O~2°C) was dissolved in water, neutralized with potassium carbonate, and salted out with common salt to remove the liberated base. Extract with CHCl3, wash with water, dry, and then distill off CHCl3. The residue is crystallized from Et2O and filtered off. Gain = 22.0f,
.. CIRv for mp119-21? ■CM-1:3300
(>NH), 1670 (5-membered ring lactam) (b) On the other hand, 18.0y of ethyl 8-oxo-2-azaerythrinane-2-carboxylate was added to 100ml of concentrated hydrochloric acid.
After heating under reflux for an hour, concentrating under reduced pressure, and recrystallizing the residue from EtOH, the hydrochloride salt was 13.0y (Mp24O~2℃).
can be obtained.

実施例58−オキソー2−アザエリスリナンー2−カル
ボキシレート(化合物番号117)(a)1−ベンジル
ー8−オキソー2−アザエリスリナン8.8yを乾燥し
たベンゼン50m1に溶解してナス型フラスコに入れ、
これに1.2倍モルのエチルクロロホルメート3.5y
を滴加し、5時間加熱還流する。
Example 58-Oxo-2-azaerythrinane-2-carboxylate (Compound No. 117) (a) 8.8y of 1-benzy-8-oxo-2-azaerythrinane was dissolved in 50ml of dry benzene and placed in an eggplant-shaped flask.
Add to this 1.2 times the mole of ethyl chloroformate 3.5y
was added dropwise and heated under reflux for 5 hours.

冷後反応後を10%塩酸で洗浄、次いで水洗し、ベンゼ
ン層を乾燥して留去する。残留物にn−ヘキサン20m
1を加えて結晶化、?取し酢酸エチルから再結晶する。
得量=7.3mp141〜2かCIRv翫■C7x−1
:1680−1690に肩(5員環ラクタムとウレタン
)(b)エチル3−エトキシカルボニルメチルー4−ピ
ペリドンー3−カルボキシレート1.28fとβ−フェ
ネチルアミン0.61ダとをトルエン20m1に溶解し
、水分除去器を付したフラスコ中で1時間加熱還流する
After cooling, the reaction mixture is washed with 10% hydrochloric acid and then with water, and the benzene layer is dried and distilled off. Add 20m of n-hexane to the residue.
Crystallize by adding 1? It is taken and recrystallized from ethyl acetate.
Amount obtained = 7.3mp141~2 or CIRv 翫 ■C7x-1
:1680-1690 (5-membered ring lactam and urethane) (b) 1.28 f of ethyl 3-ethoxycarbonylmethyl-4-piperidone-3-carboxylate and 0.61 da of β-phenethylamine were dissolved in 20 ml of toluene, Heat under reflux for 1 hour in a flask equipped with a water remover.

反応液を濃縮し、残留物にポリリン酸15yを加え、1
20℃の油浴上5時間加熱攪拌する。冷後反応液を氷水
100ccに注ぎ、クロロホルムを加えて中性物質を抽
出、水洗して乾燥し、クロロホルムを留去して残留物を
酢酸エチルから結晶化、泊取する。得量=1.10q.
.mp140.5〜1.5。CIRは前記(a)で得た
ものと同じであつた。
The reaction solution was concentrated, polyphosphoric acid 15y was added to the residue, and 1
Heat and stir on a 20°C oil bath for 5 hours. After cooling, the reaction solution is poured into 100 cc of ice water, chloroform is added to extract neutral substances, washed with water and dried, chloroform is distilled off, and the residue is crystallized from ethyl acetate and collected overnight. Yield = 1.10q.
.. mp140.5-1.5. The CIR was the same as that obtained in (a) above.

実施例62−メチルー8−オキソー2−アザエリスリナ
ン(化合物番号54)8−オキソー2−アザエリスリナ
ン4.85yをナス型フラスコに入れ、37%ホルマリ
ン2.44yとギ酸5m1を加え90℃の水浴上で3時
間加熱、冷後反応液に氷水20m1を加え、炭酸カリウ
ムで中和し、遊離する油状物をCHCl3で抽出、水洗
して乾燥し、CHCl3を留去、残留物を塩酸塩にして
結晶化、沖取しエタノールから再結晶する。
Example 6 2-Methyl-8-oxo-2-azaerythrinane (Compound No. 54) 4.85y of 8-oxo2-azaerythrinane was placed in an eggplant-shaped flask, 2.44y of 37% formalin and 5ml of formic acid were added, and the mixture was heated on a 90°C water bath for 3 hours. After heating for a period of time and cooling, 20 ml of ice water was added to the reaction solution, neutralized with potassium carbonate, the liberated oil was extracted with CHCl3, washed with water and dried, CHCl3 was distilled off, and the residue was converted into hydrochloride and crystallized. Recrystallize from ethanol taken off the coast.

塩酸塩得量=3.3y,.mp216〜8すC(Dec
.)IRvH■o−1:1700(5員環ラクタム)実
施例72−アリルー8−オキソー2−アザエリスリナン
(化合物番号55)8−オキソー2−アザエリスリナン
6.6yをアセトン50m1に溶解して二径の三角フラ
スコに入れ、これに炭酸カリウム4.2gを加えてサス
ペンドし、室温攪拌下にアリルブロマイド3.6yを滴
加する。
Amount of hydrochloride obtained = 3.3y,. mp216-8C (Dec
.. ) IRvH■o-1: 1700 (5-membered ring lactam) Example 7 2-aryl-8-oxo-2-azaerythrinane (compound number 55) 6.6y of 8-oxo-2-azaerythrinane was dissolved in 50 ml of acetone to form a two-diameter triangle. The mixture is placed in a flask, 4.2 g of potassium carbonate is added thereto, suspended, and 3.6 y of allyl bromide is added dropwise while stirring at room temperature.

滴加後室温で1時間攪拌し次いで50℃で1時間反応す
る。反応液を濃縮し残査にEt2Oを加えて水洗し、不
溶物を淵去する。Et2O溶液を濃縮し、残留物を塩酸
塩として結晶化、淵取してエタノールとエーテルより再
結晶する。塩酸塩得量=3.5ymp201〜5℃IR
pH■d−1:2500(〉N+H)、1700(5員
環ラクタム)実施例8 2−シクロプロピルメチルー8−オキソー2ーアザエリ
スリナン(化合物番号57)二径フラスコに8−オキソ
ー2−アザエリスリナン3.6yとシクロプロピルメチ
ルプロミド2.2gを入れ、DMF3OmLを加えて溶
解し、これに炭酸カリとヨードカリを加えて60〜70
℃の油浴上6時間攪拌する。
After the dropwise addition, the mixture was stirred at room temperature for 1 hour and then reacted at 50°C for 1 hour. The reaction solution was concentrated, Et2O was added to the residue, and the residue was washed with water to remove insoluble materials. The Et2O solution is concentrated and the residue is crystallized as the hydrochloride salt, filtered off and recrystallized from ethanol and ether. Hydrochloride yield = 3.5ymp201~5℃IR
pH d-1: 2500 (>N+H), 1700 (5-membered ring lactam) Example 8 2-cyclopropylmethyl-8-oxo-2-azaerythrinane (compound number 57) 8-oxo-2- in a two-bore flask Add 3.6y of azaerythrinane and 2.2g of cyclopropylmethylbromide, add 30mL of DMF and dissolve, add potassium carbonate and iodopotassium to 60~70g.
Stir for 6 hours on an oil bath at °C.

反応液を減圧下に濃縮し残査に水を加えて不溶の油状物
をCHCl3で抽出して水洗し乾燥篠QHCL3を留去
、残留物にEt2Oを加えて不溶物を戸去し、沖液を濃
縮して残留物4.05yをカラムクロマト(シリカゲル
100y1酢酸エチル)に付し精製して塩基3.1yを
得、塩酸塩として結晶化、枦取してエタノールとエーテ
ルから再結晶する。得量=2.4ymp226.5〜8
℃(Dec.)IRvKシ礪−1:1720(5員環ラ
クタム)実施例92−(N●N−ジメチルカルバモイル
メチル)−8−オキソー2−アザエリスリナン(化合物
番号58)二径の三角フラスコに8−オキソー2−アザ
エリスリナン2.4yを入れ、アセトン30m1に溶解
、これに炭酸カリ3.0ダを加えて室温攪拌下にN・N
−ジメチルクロロアセタミド1.5yを適下し、後托時
間攪拌する。
The reaction solution was concentrated under reduced pressure, water was added to the residue, the insoluble oil was extracted with CHCl3, washed with water, dried, the QHCL3 was distilled off, Et2O was added to the residue, the insoluble matter was removed, and the Oki liquid was removed. The residue (4.05y) was purified by column chromatography (silica gel 100y1 ethyl acetate) to give the base 3.1y, which was crystallized as a hydrochloride, collected and recrystallized from ethanol and ether. Yield = 2.4ymp226.5~8
°C (Dec.) IRvK cell-1:1720 (5-membered ring lactam) Example 9 2-(N●N-dimethylcarbamoylmethyl)-8-oxo-2-azaerythrinane (compound number 58) 8 in a two-diameter Erlenmeyer flask - Add 2.4y of oxo-2-azaerythrinane, dissolve in 30ml of acetone, add 3.0 da of potassium carbonate, and stir at room temperature with N.N.
- Add 1.5y of dimethylchloroacetamide dropwise and stir for an additional hour.

反応液を濃縮し、残留物を酢酸エチルに溶解して水洗、
次に10%塩酸で抽出し・て酸性液を炭酸カリで中和、
遊離塩基をCHCl3で抽出して水洗、乾燥後CHCl
3を留去する。残留物3.5yを塩酸塩にして結晶化、
淵取しエタノールとエーテルから再結晶する。得量=3
.0ymp257C(Dec.)■νK.シo−1:2
600(〉N+H)、1682(5員環ラクタム)、1
670(アミド)実施例10 8−オキソー2−(3−フェニルプロピル)一2−アザ
エリスリナン(化合物番号59)二径の三角フラスコに
8−オキソー2−アザエリスリナン3.6yと等モルの
3−フェニルプロピルクロライド2.3yを入れ、DM
F3Omlに溶解し、これに炭酸カリウム2.1yとヨ
ードカリ1.0fを加えて100℃で8時間加熱攪拌す
る。
The reaction solution was concentrated, the residue was dissolved in ethyl acetate and washed with water.
Next, extract with 10% hydrochloric acid, neutralize the acidic liquid with potassium carbonate,
The free base was extracted with CHCl3, washed with water, and dried with CHCl3.
3 is distilled off. The residue 3.5y was converted into hydrochloride and crystallized.
Strain and recrystallize from ethanol and ether. Gain = 3
.. 0ymp257C (Dec.)■νK. Sea o-1:2
600 (>N+H), 1682 (5-membered ring lactam), 1
670 (amide) Example 10 8-oxo-2-(3-phenylpropyl)-2-azaerythrinane (compound number 59) In a two-diameter Erlenmeyer flask, add 3.6y of 8-oxo-2-azaerythrinane and equimolar amount of 3-phenylpropyl. Add chloride 2.3y and DM
Dissolve in 30ml of F, add 2.1y of potassium carbonate and 1.0f of potassium iodo, and heat and stir at 100°C for 8 hours.

冷後反応液を減圧下に濃縮し、残留物に酢酸エチルを加
えて溶解し水洗、次いで10%塩酸を加えて酸可溶物を
抽出し、酸性液を炭酸カリで中和して遊離物をCHCl
3で抽出、水洗して乾燥しCHCl3を留去する。残留
物を酢酸エチルに溶解しシリカゲル25yを入れたカラ
ムを通して原料を除く、精製した塩基を塩酸塩として結
晶化、枦取してEtOH上T2Oから再結晶する。得量
=1.7y,.mp97.5〜10(代)IRv翫シα
−1:1692(5員環ラクタム)実施例112−シン
ナミルー8−オキソー2−アザエリスリナン(化合物番
号60)二径の三角フラスコに8−オキソー2−アザエ
リスリナン1.5yを入れ、アセトン30m1に溶解し
、炭酸力l月.7yを加えて室温攪拌下にシンナミルク
ロライド0.95yを滴加して後1時間攪拌する。
After cooling, the reaction solution was concentrated under reduced pressure, and the residue was dissolved in ethyl acetate and washed with water. Then, 10% hydrochloric acid was added to extract the acid-soluble materials, and the acidic solution was neutralized with potassium carbonate to remove the free materials. CHCl
3, washed with water, dried, and CHCl3 was distilled off. The residue is dissolved in ethyl acetate and passed through a column containing silica gel 25y to remove raw materials. The purified base is crystallized as a hydrochloride salt, collected and recrystallized from T2O over EtOH. Amount obtained = 1.7y,. mp97.5-10 (generation) IRv 翫 α
-1:1692 (5-membered ring lactam) Example 112-cinnamyl-8-oxo-2-azaerythrinane (compound number 60) 1.5y of 8-oxo-2-azaerythrinane was placed in a two-diameter Erlenmeyer flask, and dissolved in 30ml of acetone. Carbonic power l month. After adding 7y of cinnamyl chloride and stirring at room temperature, 0.95y of cinnamyl chloride was added dropwise and the mixture was stirred for 1 hour.

反応液を濃縮して残留物に酢酸エチルを加えて溶解し、
水洗して乾燥、酢酸エチルを留去後残留物を塩酸塩にし
て結晶化、淵取しエタノールから再結晶する。得量=1
.5ymp235〜6.5(Dec.)IRvH?礪−
1:1705(5員環ラクタム)実施例128−オキソ
ー2−フエナシルー2−アザエリスリナン(化合物番号
61)二径の三角フラスコに8−オキソー2−アザエリ
スリナン4.9fを入れ、メタノール50m1に溶解し
て、これに炭酸カリ2.8ダをサスペンドし、室温攪拌
下にフエナシルプロミド4.0yを滴加し、後室温で5
時間攪拌後50℃で1時間反応する。
Concentrate the reaction solution and dissolve the residue by adding ethyl acetate.
After washing with water and drying, ethyl acetate is distilled off, the residue is converted into a hydrochloride, crystallized, filtered, and recrystallized from ethanol. Gain = 1
.. 5ymp235~6.5 (Dec.) IRvH?礪
1:1705 (5-membered ring lactam) Example 128-oxo-2-phenacyl-2-azaerythrinane (compound number 61) 4.9 f of 8-oxo-2-azaerythrinane was placed in a two-diameter Erlenmeyer flask, and dissolved in 50 ml of methanol. To this, 2.8 y of potassium carbonate was suspended, 4.0 y of phenacyl bromide was added dropwise under stirring at room temperature, and then 5 y of potassium carbonate was added at room temperature.
After stirring for an hour, the mixture was reacted at 50° C. for 1 hour.

反一応液を濃縮して残査に水を加え、不溶の油状物をC
HCl3で抽出、水洗して乾燥(MgSO4)しCHC
l3を留去、残留物をEt2Oに溶解しシリカゲル(ク
ロマト用)10yを加えて沖過、Et2O洗浄して?液
を濃縮し残留物5.3yを塩酸塩にして結晶化、泪取し
エタノールとエーテルから再結晶する。得量=3.3f
..mp223〜3.5℃(Dec.)■ν二ニζo−
1:1696(5員環ラクタム、カルボニル)実施例1
3 2−(2−ベンゾイルエチル)−8−オキソー2−アザ
エリスリナン(化合物番号62)ナス型フラスコに8−
オキソー2−アザエリス1リナン塩酸塩7.0gとアセ
トフェノン3.6qおよびバラホルムアルデヒド2.7
fを入れ、エタノール100n1を加えて131V間加
熱還流する。
Concentrate the reaction solution, add water to the residue, and remove the insoluble oil with C.
Extract with HCl3, wash with water, dry (MgSO4) and extract with CHC
13 was distilled off, the residue was dissolved in Et2O, 10y of silica gel (for chromatography) was added, filtered, and washed with Et2O. The solution was concentrated, and the residue (5.3y) was converted into a hydrochloride, crystallized, filtered, and recrystallized from ethanol and ether. Gain = 3.3f
.. .. mp223~3.5℃ (Dec.)■ν2ζo-
1:1696 (5-membered ring lactam, carbonyl) Example 1
3 2-(2-benzoylethyl)-8-oxo-2-azaerythrinane (compound number 62) was placed in an eggplant-shaped flask.
Oxo 2-azaerys 1 linane hydrochloride 7.0g, acetophenone 3.6q and paraformaldehyde 2.7
f, add 100 n1 of ethanol, and heat under reflux for 131 V.

反応液を濃縮して残査をH2Oに溶解し、炭酸カリで中
和後CHCl3で抽出、水洗して乾燥し、CHCl3を
留去す・る。残留物8.7yをカラムクロマト(シリカ
ゲル25y1酢酸エチル溶媒使用)に付し精製、7.3
yの塩基を得、塩酸塩として結晶化、淵取してエタノー
ルとエーテルから再結晶する。得量=5.2f..mp
166.5〜7.5℃1Rp?■Cm−1:1708(
カルボニル)、1690(5員環ラクタム)実施例14 3−(3−ベンゾイルプロピル)−8−オキソー2−ア
ザエリスリナン(化合物番号63)二径の三角フラスコ
に8−オキソー2−アザエリスリナン3.6yと4.4
−エチレンジオキシー4−フェニルブチルクロライド3
.4yを加え、DMF′50m1に溶解してこれに炭酸
カリ2.1yとヨードカリ1.0yを加えて140℃の
油浴上8時間加熱攪拌する。
The reaction solution was concentrated, the residue was dissolved in H2O, neutralized with potassium carbonate, extracted with CHCl3, washed with water, dried, and CHCl3 was distilled off. Residue 8.7y was purified by column chromatography (using silica gel 25y1 ethyl acetate solvent), 7.3
The base of y is obtained, crystallized as the hydrochloride salt, filtered off and recrystallized from ethanol and ether. Gain = 5.2f. .. mp
166.5-7.5℃ 1Rp? ■CM-1:1708(
Carbonyl), 1690 (5-membered ring lactam) Example 14 3-(3-benzoylpropyl)-8-oxo-2-azaerythrinane (Compound No. 63) 8-oxo-2-azaerythrinane 3.6y and 4 were placed in a two-bore Erlenmeyer flask. .4
-ethylenedioxy-4-phenylbutyl chloride 3
.. 4y was added, dissolved in 50ml of DMF', 2.1y of potassium carbonate and 1.0y of potassium iodo were added thereto, and the mixture was heated and stirred on an oil bath at 140°C for 8 hours.

反応液を減圧下に濃縮し、残査に水を加え、不溶の油状
物をCHCl3で抽出、水洗して乾燥(MgSO4)篠
?HCl3を留去する。次に残留物を濃塩酸50Tn1
とエタ,′−ル50m1の混合液に溶解して2時間加熱
還流、反応液を濃縮して残査を氷水に溶解、炭酸カリで
中和して遊離物をCHCl3抽出、水洗して乾燥(Mg
SO4)篠?HCl3を留去し残留物を塩酸塩として結
晶化、泊取してエタノールから再結晶する。得量=4.
4ダ、Mp232〜3℃■ν振Nc!n−1:1696
(5員環ラクタム、カルボニル)実施例15 2−(3−ハイドロキシー3−フェニルプロピル)−8
−オキソー2−アザエリスリナン(化合物番号67)三
角フラスコに2−(2−ベンゾイル)−8−オキソー2
−アザエリスリナン2.36yを入れ、エタノール30
m1に溶解して室温攪拌下にNaBH43OOm9を添
加する。
The reaction solution was concentrated under reduced pressure, water was added to the residue, the insoluble oil was extracted with CHCl3, washed with water and dried (MgSO4). HCl3 is distilled off. Next, remove the residue with 50Tn1 of concentrated hydrochloric acid.
The mixture was dissolved in a mixture of 50 ml of ethanol and ethanol, and heated under reflux for 2 hours. The reaction solution was concentrated, the residue was dissolved in ice water, neutralized with potassium carbonate, and the free substances were extracted with CHCl3, washed with water, and dried ( Mg
SO4) Shino? HCl3 is distilled off and the residue is crystallized as a hydrochloride salt, collected and recrystallized from ethanol. Amount obtained = 4.
4 da, Mp232~3℃■ν vibration Nc! n-1:1696
(5-membered ring lactam, carbonyl) Example 15 2-(3-hydroxy 3-phenylpropyl)-8
-Oxo2-azaerythrinane (compound number 67) in an Erlenmeyer flask with 2-(2-benzoyl)-8-oxo2
-Add 2.36y of azaerythrinane and 30y of ethanol
Add NaBH43OOm9 dissolved in m1 and stirring at room temperature.

室温で5時間攪拌後50℃に加温して1時間反応する。
反応液を濃縮して残留物をCHCl3に溶解して水洗し
、CHCl3層を乾燥して留去する。残留物をカラムク
ロマト(シリカゲル50y、エタノール)に付し精製し
て油状塩基1.9yを得、塩酸塩として結晶化、結晶化
しないため、溶媒を蒸発乾固して粉末状とする。得量=
1.9y(吸湿性)実施例16 2−フルフリルー8−オキソー2−アザエリスリナン(
化合物番号69)二径の三角フラスコに8−オキソー2
−アザエリスリナン2.0gを入れ、アセトン10m1
に溶解して、これに炭酸力1月.0yを加えて室温攪拌
下にフルフリルクロライド1.0v(7)Et2O溶液
を滴加し後室温で1叫間攪拌する。
After stirring at room temperature for 5 hours, the mixture was heated to 50°C and reacted for 1 hour.
The reaction solution was concentrated, the residue was dissolved in CHCl3 and washed with water, and the CHCl3 layer was dried and distilled off. The residue was purified by column chromatography (50 y of silica gel, ethanol) to obtain 1.9 y of an oily base, which crystallized as a hydrochloride. Since it did not crystallize, the solvent was evaporated to dryness to form a powder. Gain =
1.9y (hygroscopicity) Example 16 2-furfuryl-8-oxo-2-azaerythrinane (
Compound No. 69) 8-oxo 2 in a two-diameter Erlenmeyer flask
- Add 2.0g of azaerythrinane and 10ml of acetone.
Dissolved in this and carbonated it for 1 month. After adding 0y and stirring at room temperature, a 1.0v (7) Et2O solution of furfuryl chloride was added dropwise, and the mixture was stirred for one hour at room temperature.

反応液を濃縮して残査に水を加え不溶の油状物を酢酸エ
チルで抽出、水洗して乾燥(MgSO,)後酢酸エチル
を留去し残留物を塩酸塩にして結晶化、淵取し水+アセ
トンから再結晶する。得量=2.5y,.mp215〜
20℃(Dec.)IRv抵■d−1:3500(結晶
水)、1680(5貝環ラクタム)実施例17 2−テトラハイドロフルフリルー8−オキソー2−アザ
エリスリナン(化合物番号71)二径の三角フラスコに
8−オキソー2−アザエ.リスリナン2.7ダを入れ、
アセトン15m1に溶解して、これに炭酸カリ2.0y
を加え室温攪拌下にテトラハイドロフルフリルプロミド
2.1yを滴加し、後反応液を5時間加熱還流する。
The reaction solution was concentrated, water was added to the residue, and the insoluble oil was extracted with ethyl acetate, washed with water and dried (MgSO,), then the ethyl acetate was distilled off, the residue was converted into a hydrochloride, crystallized, and filtered off. Recrystallize from water + acetone. Amount obtained = 2.5y,. mp215~
20°C (Dec.) IRv resistance d-1: 3500 (crystal water), 1680 (5-shell lactam) Example 17 2-tetrahydrofurfuryru-8-oxo-2-azaerythrinane (compound number 71) Two-diameter triangular Add 8-oxo-2-azae to the flask. Add 2.7 Da of Risurinan,
Dissolve in 15ml of acetone and add 2.0y of potassium carbonate to this.
2.1y of tetrahydrofurfuryl bromide was added dropwise while stirring at room temperature, and the reaction mixture was then heated under reflux for 5 hours.

反応液を濃縮して残査に水を加え不溶の油状物を酢酸エ
チル.で抽出し、水洗乾燥(MgSO4)後酢酸エチル
を留去し残留物を塩酸塩として結晶化、枦取してエタノ
ールとエーテルから再結晶する。得量=2.0q..m
p230〜5再C(Dec.)IRv??C77l−1
:1690(5員環ラクタム)実施例1815−ニトロ
ー8−オキソー2−アザエリスリナン(化合物番号53
)三径フラスコに8−オキソー2−アザエリスリナン塩
酸塩8.4Vを入れ、これに濃硫酸50m1を加えて溶
解する。
The reaction solution was concentrated, water was added to the residue, and the insoluble oil was extracted with ethyl acetate. After washing with water and drying (MgSO4), the ethyl acetate was distilled off, and the residue was crystallized as a hydrochloride, collected and recrystallized from ethanol and ether. Yield = 2.0q. .. m
p230~5 ReC (Dec.) IRv? ? C77l-1
:1690 (5-membered ring lactam) Example 1815-Nitro-8-oxo-2-azaerythrinane (Compound No. 53
) 8.4V of 8-oxo-2-azaerythrinane hydrochloride is placed in a three-bore flask, and 50ml of concentrated sulfuric acid is added to dissolve it.

反応液を0〜5℃に冷却し攪拌しながら濃硝酸11nL
を徐々に滴加する。この間反応温度を5〜10℃に保つ
。滴加後10℃で4時間攪拌を続け後反応液を氷水20
0m1中に注ぎ、冷却下にアンモニア水で中和する。遊
離物をCHCl3で2回抽出し、CHCl3層を水洗乾
燥してCHCl3を留去する。残留物を結晶化せしめて
枦取し冷アセトンで洗浄、アセトンから再結晶する。得
量=8.0y1ノMpl6O〜2℃、塩酸塩Mp3O8
℃(Dec.)■ν瓢Nc77!−1:3305(〉N
H)、1685(5員環ラクタム)、1522、135
0(−NO2)、NMR(CDCl3)δ:8.41(
1H1タブレット、J=2.5Hz);Cl4−H1&
11(1H..d−D,.J=8.5s2.5Hz)C
l6−Hl7.35(1H1タブレット、J=8.5H
2);Cl7−H実施例19 2−ベンジルー8−オキソー11a−プロピオニルー2
●11aージアザーC−ホモエリスリナン(化合物番号
138)2−ベンジルー8−オキソー2●11aージア
ザーC−ホモエリスリナン30ダにプロピオン酸無水物
60fを加え120℃の油浴上2時間加熱する。
Cool the reaction solution to 0-5℃ and add 11 nL of concentrated nitric acid while stirring.
Gradually add dropwise. During this time, the reaction temperature is maintained at 5-10°C. After the dropwise addition, stirring was continued at 10℃ for 4 hours, and the reaction solution was poured into ice water for 20 minutes.
Pour into 0ml and neutralize with aqueous ammonia while cooling. The educts are extracted twice with CHCl3, the CHCl3 layer is washed with water and dried, and CHCl3 is distilled off. The residue is crystallized, washed with cold acetone, and recrystallized from acetone. Amount obtained = 8.0y1Mpl6O~2℃, hydrochloride Mp3O8
℃(Dec.)■ν瓢Nc77! -1:3305(>N
H), 1685 (5-membered ring lactam), 1522, 135
0 (-NO2), NMR (CDCl3) δ: 8.41 (
1H1 tablet, J=2.5Hz);Cl4-H1&
11 (1H..d-D,.J=8.5s2.5Hz)C
l6-Hl7.35 (1H1 tablet, J=8.5H
2); Cl7-H Example 19 2-benzyl-8-oxo 11a-propionyl-2
●11a-diaza C-homoerythrinane (Compound No. 138) 2-benzy-8-oxo 2●11a-diaza C-homoerythrinane 60 f is added to 30 da of 11a-diaza C-homoerythrinane and heated on an oil bath at 120°C for 2 hours.

反応液を減圧下に濃縮し、残留物に氷水を加え炭酸カリ
でアルカリ性とした後遊離の塩基を酢酸エチルで抽出、
水洗して乾燥後酢酸エチルを留去し、残留物を塩酸塩と
して結晶化、泊取しエタノールから再結晶する。得量=
27.0y,smp285〜94℃(Dec.)〔塩基
Mpl54〜5℃)爪ν二?礪−1:1700(5員環
ラクタム)、1650(アミド)実施例20 11a−アリルー2−ベンジルー8−オキソー2・11
aージアザーC−ホモエリスリナン(化合物番号139
)2−ベンジルー8−オキソー2・11aージアザーC
−ホモエリスリナン500m9を乾燥したトルエン3m
1に加熱溶解し、これにナトリウムアミドの粉末110
mgを加えて1時間加熱還流する。
The reaction solution was concentrated under reduced pressure, ice water was added to the residue, the mixture was made alkaline with potassium carbonate, and the free base was extracted with ethyl acetate.
After washing with water and drying, ethyl acetate is distilled off, and the residue is crystallized as a hydrochloride salt, taken overnight, and recrystallized from ethanol. Gain =
27.0y, smp285~94℃(Dec.) [Base Mpl54~5℃) Nail ν2?礪-1: 1700 (5-membered ring lactam), 1650 (amide) Example 20 11a-aryl-2-benzyl-8-oxo 2.11
a-diazer C-homoerythrinane (compound number 139
) 2-benzyru-8-oxo 2.11a diazur C
- 3 m of toluene with 500 m9 of homoerythrinane dried
1 and add 110% sodium amide powder to it.
mg and heated under reflux for 1 hour.

冷後アリルプロミド750m9を滴加し、60℃で約川
侍間加熱攪拌する。反応後を減圧下に濃縮して残査に水
を加えて不溶の油状物をCHCl3で抽出、水洗して乾
燥後QHCl3を留去する。残留物に少量をエタノール
を加えて結晶化し枦取、酢酸エチルから再結晶する。得
量=250m9、Mpl46〜8℃、塩酸塩(EtOH
上T2O)Mp25O〜600c(Dec.)■ν振N
c77!−1:1700(5員環ラクタム)実施例21
8−オキソー2−フェネチルーB−ホモー2●11a−
ジアザエリスリナン(化合物番号116)8−オキソー
2−フェネチルー11a−プロピオニルーB−ホモー2
・11a−ジアザエリスリナン塩酸塩3.0gを45%
硫酸溶液50m1に溶解し、50時間加熱還流する。
After cooling, 750 m9 of allylpromide was added dropwise, and the mixture was heated and stirred at 60°C for about a minute. After the reaction, the residue is concentrated under reduced pressure, water is added to the residue, and the insoluble oil is extracted with CHCl3, washed with water, dried, and QHCl3 is distilled off. A small amount of the residue is crystallized by adding ethanol, collected, and recrystallized from ethyl acetate. Yield = 250 m9, Mpl46-8°C, hydrochloride (EtOH
Upper T2O) Mp25O~600c (Dec.) ■ν vibration N
c77! -1:1700 (5-membered ring lactam) Example 21
8-oxo 2-phenethyl B-homo 2●11a-
Diazaerythrinane (Compound No. 116) 8-oxo-2-phenethyl-11a-propionyl-B-homo2
・11a-diazaerythrinane hydrochloride 3.0g 45%
Dissolve in 50 ml of sulfuric acid solution and heat under reflux for 50 hours.

冷後反応液を炭酸カリウムで中和し、遊離する塩基をク
ロロホルムで抽出、水洗、乾燥してクロロホルムを留去
する。残留物を酢酸エチルから結晶化し、同溶媒から再
結晶する。得量=0.501mp177〜80゜C1塩
酸塩(エタノ−ルーエーテルから再結晶)Mp2OO〜
5℃(Dec.)IRv?N礪−1:3300(〉NH
)、1670(ラクタム環)実施例22 2−ベンジルー15−ハイドロキシー8−オキソー2−
アザエリスリナン(化合物番号142)2−ベンジルー
15−メトキシー8−オキソー2ーアザエリスリナン塩
酸塩4.0gを48%臭化水素酸25m1に溶解し2時
間加熱還流する。
After cooling, the reaction solution is neutralized with potassium carbonate, the liberated base is extracted with chloroform, washed with water, dried, and the chloroform is distilled off. The residue is crystallized from ethyl acetate and recrystallized from the same solvent. Amount obtained = 0.501mp177~80°C1 hydrochloride (recrystallized from ethanol-ether) Mp2OO~
5℃ (Dec.) IRv? N-1:3300 (〉NH
), 1670 (lactam ring) Example 22 2-benzyl-15-hydroxy 8-oxo 2-
Azaerythrinane (Compound No. 142) 4.0 g of 2-benzy-15-methoxy-8-oxo-2-azaerythrinane hydrochloride was dissolved in 25 ml of 48% hydrobromic acid and heated under reflux for 2 hours.

反応液を減圧下に濃縮して残査に氷水を加すて溶解し、
アンモニア水でアルカリ性として析出する結晶を■取し
てエタノールから再結晶する。得量=2.9y1mp2
10〜3゜CIRv?X↓Cm−1:3180(−0H
)、1650(5員環ラクタム)実施例23 17−ハイドロキシー8−オキソー2−アザエリスリナ
ン(化合物番号144)17−メトキシー8−オキソー
2−アザエリスリナン3.8yを48%臭化水素酸10
mtに溶解して2時間加熱還流する。
The reaction solution was concentrated under reduced pressure, and the residue was dissolved by adding ice water.
The crystals that precipitate as alkaline with aqueous ammonia are taken out and recrystallized from ethanol. Amount obtained = 2.9y1mp2
10~3°CIRv? X↓Cm-1:3180(-0H
), 1650 (5-membered ring lactam) Example 23 17-hydroxy 8-oxo 2-azaerythrinane (compound number 144) 17-methoxy 8-oxo 2-azaerythrinane 3.8y was dissolved in 48% hydrobromic acid 10
mt and heated under reflux for 2 hours.

反応液を減圧下に濃縮し、残査を氷水15m1に溶解し
てアンモニア水でアルカリ性とする。析出する結晶を淵
取し、水洗後エタノールで洗浄して風乾。得量=3.5
y,.mp308゜C(Dec.)(エタノールから再
結晶)IRv?綱礪−1:340へ3260(−0H1
〉NH)、1682(5員環ラクタム)実施例24 2−アリルー17−ハイドロキシー8−オキソー2−ア
ザエリスリナン(化合物番号147)17−ハイドロキ
シー8−オキソー2−アザエリスリナン1.0yをDM
SO3OmLにサスペンドし、これに重炭酸ソーダ1.
5yを加え室温攪拌下にアリルプロミドを滴加し、40
℃で1叫間攪拌を続ける。
The reaction solution was concentrated under reduced pressure, and the residue was dissolved in 15 ml of ice water and made alkaline with aqueous ammonia. Collect the precipitated crystals, wash with water and ethanol, and air dry. Gain = 3.5
y,. mp308°C (Dec.) (recrystallized from ethanol) IRv? Tsunatan -1:340 to 3260 (-0H1
〉NH), 1682 (5-membered ring lactam) Example 24 2-aryl-17-hydroxy-8-oxo-2-azaerythrinane (compound number 147) DM 1.0y of 17-hydroxy-8-oxo-2-azaerythrinane
Suspend in SO3OmL and add 1.0ml of bicarbonate of soda to this.
Add 5y and add allyl bromide dropwise while stirring at room temperature.
Continue stirring at ℃ for 1 hour.

反応液を氷水80mLに加え、10%塩酸で酸性とした
後アンモニア水でアルカリ性とし酢酸エチルで抽出、有
機層に10%NaOH溶液を加えてアルカリ可溶物を3
回抽出し、NaOU?液を酸性とした後アンモニア水で
アルカリ性としCHCl3抽出して水洗乾燥桟QHCl
3を留去する。残留物0.95yを塩酸塩として結晶化
、泊取してエタノールとエーテルから再結晶する。得量
=0.85y.smp276℃(Dec.)IRpH:
↓C77!−1:3120(−0H)、1675(5員
環ラクタム)実施例25 2−アリルー16−(ハイドロキシー8−オキソー2−
アザエリスリナン(化合物番号150)16−ハイドロ
キシー8−オキソー2−アザエリスリナン1.0yをD
MF25mtに加温溶解して放冷し、冷後重炭酸ソーダ
1.5Vを加えて室温攪拌下にアリルプロミド0.50
gを滴加し、■時間室温で攪拌後40℃で2時間反応す
る。
The reaction solution was added to 80 mL of ice water, made acidic with 10% hydrochloric acid, made alkaline with ammonia water, extracted with ethyl acetate, and added 10% NaOH solution to the organic layer to remove alkali-soluble materials.
Extract twice, NaOU? After making the liquid acidic, it was made alkaline with ammonia water, extracted with CHCl3, washed with water and dried with QHCl.
3 is distilled off. The residue (0.95y) was crystallized as a hydrochloride, collected and recrystallized from ethanol and ether. Yield = 0.85y. smp276℃(Dec.)IRpH:
↓C77! -1:3120 (-0H), 1675 (5-membered ring lactam) Example 25 2-aryl 16-(hydroxy 8-oxo 2-
Azaerythrinane (Compound No. 150) 1.0y of 16-hydroxy-8-oxo-2-azaerythrinane was D
Dissolve in MF25mt by heating, let stand to cool, add 1.5V of sodium bicarbonate after cooling, and add 0.50V of allylpromide while stirring at room temperature.
After stirring at room temperature for 1 hour, the mixture was reacted at 40°C for 2 hours.

反応液を濃縮し、残査に水を加えて不溶の油状物を酢酸
エチルで抽出、有機層に5%NaOH水溶液を加えてア
ルカリ可溶物を抽出し、アルカリ液を酸性とした後次に
アンモニア水でアルカリ性としCHCl3で抽出、水洗
して乾燥しCHCl3を留去、残留物をエーテルで”結
晶化、淵取してエーテルから再結晶する。塩基得量=6
70m9、Mp2O3〜5結C(塩酸塩Mpl99〜2
00℃(Dec.))IRvH?Cm−1:3400〜
2500(〉N+H)、1688(5員環ラグ多ム)実
施例29 8−オキソー2−アザエリスリナンの光学分割(化合物
番号167)L−(+)一酒石酸13.6Vと等モルの
8−オキソー2−アザエリスリナン22.0gをエタノ
ール゛350mtに加熱溶解して放冷する。
Concentrate the reaction solution, add water to the residue, extract the insoluble oil with ethyl acetate, add 5% NaOH aqueous solution to the organic layer to extract the alkali-soluble matter, make the alkali solution acidic, and then It is made alkaline with aqueous ammonia, extracted with CHCl3, washed with water and dried, CHCl3 is distilled off, the residue is crystallized with ether, filtered off and recrystallized from ether. Amount of base obtained = 6
70m9, Mp2O3~5 C (hydrochloride Mpl99~2
00℃(Dec.))IRvH? Cm-1: 3400~
2500 (>N+H), 1688 (5-membered ring lagtam) Example 29 Optical resolution of 8-oxo-2-azaerythrinane (compound number 167) L-(+) monotartrate 13.6V and equimolar 8-oxo-2 - 22.0 g of azaerythrinane was heated and dissolved in 350 mt of ethanol and allowed to cool.

4時間後に析出晶を枦取し、粗結晶を90%含水エタノ
ール700mtから再結晶する。
After 4 hours, the precipitated crystals are collected and the crude crystals are recrystallized from 700 mt of 90% aqueous ethanol.

合わせて3回再結晶し11.7yを得る。Mp223℃
(Dec.)無色針状晶〔α〕肌6=85.9D(C=
1.003飄H2O)最初の母液と一次再結晶母液を濃
縮し、残査を水に溶解後炭酸カリウムで中和、遊離する
塩基をクロロホルムで抽出、水洗、乾燥してクロロホル
ムを留去し、残留物11.29を得る。この粗塩基と等
モルのD−(−)一酒石酸6.8yを90%含水エタノ
ール300m1に加熱溶解して放冷する。4時間後析出
晶をp取し、前記と同様に90%含水エタノールから再
結晶を3回行う。
Recrystallize a total of three times to obtain 11.7y. Mp223℃
(Dec.) Colorless needle crystals [α] Skin 6 = 85.9D (C =
1.003 kg H2O) Concentrate the first mother liquor and the primary recrystallization mother liquor, dissolve the residue in water, neutralize with potassium carbonate, extract the liberated base with chloroform, wash with water, dry and distill off the chloroform. A residue of 11.29 is obtained. 6.8 y of D-(-) monotartaric acid in an equimolar amount to this crude base was dissolved by heating in 300 ml of 90% aqueous ethanol and allowed to cool. After 4 hours, the precipitated crystals are collected and recrystallized three times from 90% aqueous ethanol in the same manner as above.

得量9.2y..mp2230C(Dec.)以上の様
にして得た各酒石酸塩を水に溶解し炭酸カリウムで中和
して、遊離塩基を抽出し、結晶化、エーテルから再結晶
する。
Yield: 9.2y. .. mp2230C (Dec.) Each tartrate salt obtained as above is dissolved in water, neutralized with potassium carbonate, free base is extracted, crystallized and recrystallized from ether.

(十)−8−オキソー2−アザエリスリナンニ得量=6
.1y..mp151〜2℃ 〔α〕芭3.6=112
.80(C=1.07&エタノール)(−)−8−オキ
ソー2−アザエリスナンニ得量=5.0y.smp15
1〜2エC〔α〕=炉.6=ー112.8.(C=1.
087、エタノール)実施例30(+)−2−(3−メ
チルー2−ブテニル)一8−オキソー2−アザエリスリ
ナン(化合物番号168)(+)−8−オキソー2−ア
ザエリスリナン1.50yをアセトン30mtに溶解し
、これに炭酸カリウム1.70yをサスペンドし、室温
攪拌下に3−メチルー2−ブテニルプロミド0.95q
を滴加し、後室温で(イ)時間攪拌する。
(10)-8-oxo2-azaerythrinanni yield = 6
.. 1y. .. mp151~2℃ [α] Bass 3.6=112
.. 80 (C=1.07&ethanol)(-)-8-oxo-2-azaerythnanni yield=5.0y. smp15
1~2EC [α] = Furnace. 6=-112.8. (C=1.
087, ethanol) Example 30 (+)-2-(3-Methyl-2-butenyl)-8-oxo-2-azaerythrinane (Compound No. 168) (+)-8-oxo-2-azaerythrinane (1.50y) in 30mt of acetone Dissolve, suspend 1.70y of potassium carbonate, and add 0.95q of 3-methyl-2-butenyl bromide while stirring at room temperature.
was added dropwise, and then stirred at room temperature for (a) hours.

反応液を濃縮し、残留物に酢酸エチルを加えて溶解、水
洗、乾燥して溶媒を留去する。残留物をエタノール性塩
酸て処理し、塩酸塩として結晶化、沖取、風乾する。得
量=2.0y1エタノ−ルーアセトンから再結晶する。
Mp2l9〜20゜C(Dec.)、〔α〕?=70.
90(C=1.215へエタノール)(一)−2−(3
−メチルー2−ブテニル)−8−オキソー2−アザエリ
スリナン(一)−8−オキソー2−アザエリスリナンを
用い、前記(+)体と同量を同じ方法で反応および後処
理をして得る。
The reaction solution was concentrated, the residue was dissolved in ethyl acetate, washed with water, dried, and the solvent was distilled off. The residue is treated with ethanolic hydrochloric acid, crystallized as a hydrochloride salt, collected, and air-dried. Yield = 2.0y1 Recrystallized from ethanol-acetone.
Mp2l9~20°C (Dec.), [α]? =70.
90 (ethanol to C=1.215) (1)-2-(3
-Methyl-2-butenyl)-8-oxo-2-azaerythrinane (1)-8-oxo-2-azaerythrinane is used in the same amount as the above (+) form by reaction and post-treatment in the same manner.

得量:2.0y..mp219〜20℃(Dec.)実
施例31 (+)−2−シンナミルー8−オキソー2−アザエリス
リナン(化合物番号169)(+)−8−オキソー2−
アザエリスリナン1.50yをアセトン30Tn1に溶
解し、これに炭酸カリウム1.70yをサスペンドし、
室温攪拌下にシンナミルプロミド0.95gを滴加し、
後室温で2峙間攪拌する。
Yield: 2.0y. .. mp219-20°C (Dec.) Example 31 (+)-2-Cinnamyl-8-oxo-2-azaerythrinane (Compound No. 169) (+)-8-oxo-2-
Dissolve 1.50y of azaerythrinane in 30Tn1 of acetone, suspend 1.70y of potassium carbonate therein,
Add 0.95 g of cinnamyl bromide dropwise while stirring at room temperature,
After that, the mixture was stirred for two hours at room temperature.

反応液を濃縮し、残査に酢酸エチルを加えて抽出、水洗
、乾燥して溶媒を留去する。残留物にエーテルを加え、
不溶物を戸去、淵液にエタノール性塩酸を加えて塩酸塩
として結晶化、戸取する。得量=2.0y1エタノール
から再結晶する。Mp24O〜2℃(Dec.)、〔α
〕?=51.00(C=1.03表水)(−)体も前記
と同様に反応、後処理をする。
The reaction solution was concentrated, the residue was extracted with ethyl acetate, washed with water, dried, and the solvent was distilled off. Add ether to the residue,
Insoluble matter is removed, and ethanolic hydrochloric acid is added to the bottom liquid to crystallize it as a hydrochloride, which is removed. Yield = 2.0y1 Recrystallized from ethanol. Mp24O~2℃(Dec.), [α
]? =51.00 (C=1.03 surface water) The (-) body is also reacted and post-treated in the same manner as above.

得量=1.5y..mp240〜2理C(Dec.)、
〔α〕芭3=ー50.8.(C=1.097\H2O)
実施例32 (十)−8−オキソー2−フェネチルー2−アザエリス
リナン(化合物番号170)(+)−8−オキソー2−
アザエリスリナン1.5gをDMF2OmLに溶解し、
これに炭酸カリウム1.70yとヨウドカリウム1.0
yをサスペンドし、室温攪拌下にβ−フェネチルプロミ
ド1.20yを滴加、後80〜90℃の油浴上15A間
攪拌を続ける。
Yield = 1.5y. .. mp240~2 Logic (Dec.),
[α] Bas 3 = -50.8. (C=1.097\H2O)
Example 32 (10)-8-oxo2-phenethyl-2-azaerythrinane (compound number 170) (+)-8-oxo2-
Dissolve 1.5 g of azaerythrinane in 20 mL of DMF,
This includes 1.70y of potassium carbonate and 1.0y of potassium iodide.
y was suspended, 1.20 y of β-phenethylbromide was added dropwise while stirring at room temperature, and stirring was continued for 15 A on an oil bath at 80 to 90°C.

冷後反応液を氷水に注ぎ、酢酸エチルを加えて抽ノ出、
水洗、乾燥して溶媒を留去する。残留物をエタノールに
溶解し、これにβ−ナフタレンスルホン酸を加えて濃縮
、残査を結晶化、泊取、アセトン洗浄し、アセトンから
再結晶する。得量=2.5f..mp209〜12℃、
〔α〕?=52.3芭7(C=1.6へエタノール)(
一)体も前記と同様に反応、後処理をする。
After cooling, pour the reaction solution into ice water, add ethyl acetate and extract.
Wash with water, dry and remove the solvent. The residue is dissolved in ethanol, β-naphthalenesulfonic acid is added thereto and concentrated, and the residue is crystallized, collected, washed with acetone, and recrystallized from acetone. Gain = 2.5f. .. mp209~12℃,
[α]? = 52.3 7 (ethanol to C = 1.6) (
1) The body is also reacted and post-treated in the same manner as above.

Claims (1)

【特許請求の範囲】 1 次の一般式〔 I 〕で表わされる8−オキソ−2−
アザエリスリナン誘導体およびその酸付加塩。 ▲数式、化学式、表等があります▼〔 I 〕ただし、Y
は▲数式、化学式、表等があります▼、▲数式、化学式
、表等があります▼、▲数式、化学式、表等があります
▼、▲数式、化学式、表等があります▼、又は−(CH
_2)m−(ここにmは0又は1を表わす。 )を表わし、mは1又は2を表わし、R_1及びR_2
は同一又は異なつて水素、低級アルコキシ、ハロゲン又
は水酸基を表わし、R_3は水素、低級アルキル、低級
アルコキシ、ハロゲン、ニトロ基、又は水酸基を表わす
。但しR_2とR_3は合してテトラメチレンを表わし
ても良い。R_4は水素、低級アルキル、低級アルコキ
シカルボニル、▲数式、化学式、表等があります▼(R
_5、R_6は同一又は異なつて、水素、低級アルキル
又はフェニルを表わす。 )、▲数式、化学式、表等があります▼(ここにmは1
、2又は3を表わす。 )、▲数式、化学式、表等があります▼(ここにmは1
、2又は3を表わし、R_7は水素、ハロゲン、低級ア
ルキル又は低級アルコキシを表わす。 )、▲数式、化学式、表等があります▼(ここにmは1
、2又は3を表わす。 )、▲数式、化学式、表等があります▼(ここにR_8
は水素又は低級アルキルを表わす。 )、−CH_2C≡CH、▲数式、化学式、表等があり
ます▼、▲数式、化学式、表等があります▼、▲数式、
化学式、表等があります▼、又は▲数式、化学式、表等
があります▼を表わす。 また、■部は不飽和結合か又は飽和結合を表わす。
[Claims] 8-oxo-2- represented by the following general formula [I]
Azaerythrinane derivatives and acid addition salts thereof. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [I] However, Y
▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼, or - (CH
_2) m- (here m represents 0 or 1), m represents 1 or 2, R_1 and R_2
are the same or different and represent hydrogen, lower alkoxy, halogen, or hydroxyl group, and R_3 represents hydrogen, lower alkyl, lower alkoxy, halogen, nitro group, or hydroxyl group. However, R_2 and R_3 may collectively represent tetramethylene. R_4 is hydrogen, lower alkyl, lower alkoxycarbonyl, ▲numerical formula, chemical formula, table, etc.▼(R
_5 and R_6 are the same or different and represent hydrogen, lower alkyl or phenyl. ), ▲Mathematical formulas, chemical formulas, tables, etc.▼(Here m is 1
, 2 or 3. ), ▲Mathematical formulas, chemical formulas, tables, etc.▼(Here m is 1
, 2 or 3, and R_7 represents hydrogen, halogen, lower alkyl or lower alkoxy. ), ▲Mathematical formulas, chemical formulas, tables, etc.▼(Here m is 1
, 2 or 3. ), ▲Mathematical formulas, chemical formulas, tables, etc.▼(R_8 here
represents hydrogen or lower alkyl. ), -CH_2C≡CH, ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼, ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼, ▲ Mathematical formulas,
Represents ▼, which has chemical formulas, tables, etc., or ▲, which has mathematical formulas, chemical formulas, tables, etc. In addition, part (■) represents an unsaturated bond or a saturated bond.
JP55009175A 1980-01-28 1980-01-28 2-Azaerythrinane derivative Expired JPS6043350B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55009175A JPS6043350B2 (en) 1980-01-28 1980-01-28 2-Azaerythrinane derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55009175A JPS6043350B2 (en) 1980-01-28 1980-01-28 2-Azaerythrinane derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP60057038A Division JPS60214789A (en) 1985-03-19 1985-03-19 2-azaerythrinan derivative

Publications (2)

Publication Number Publication Date
JPS56108789A JPS56108789A (en) 1981-08-28
JPS6043350B2 true JPS6043350B2 (en) 1985-09-27

Family

ID=11713229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55009175A Expired JPS6043350B2 (en) 1980-01-28 1980-01-28 2-Azaerythrinane derivative

Country Status (1)

Country Link
JP (1) JPS6043350B2 (en)

Also Published As

Publication number Publication date
JPS56108789A (en) 1981-08-28

Similar Documents

Publication Publication Date Title
KR100352212B1 (en) Method for preparing 4a, 5,9,10,11,12-hexahydro-6H-benzofuro [3a, 3,2-ef] [2] benzazin derivative
PT1543002E (en) Preparation of 1h-imidazo 4,5-c
EP2888268A1 (en) Novel spirooxindole derivative and process for producing the same
US5138060A (en) Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
AU642402B2 (en) 2-amino-7-hydroxytetralin carboxyalkyl ethers
US6369238B1 (en) Processes for the preparation of derivatives of 4a, 5, 9, 10, 11, 12-hexahydro-6H-benzofuro-[3a, 3, 2-ef][2]benzazepine
US4859664A (en) Derivatives of 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonines and -1,4-benzoxazonines, processes for their production and their use as pharmaceuticals
TWI629261B (en) Preparation method of bovasacetam
JPS6043350B2 (en) 2-Azaerythrinane derivative
PT842153E (en) (-) - (1R, 5S, 2 &#34;R) -3&#39;-HYDROXY-2- (2-METHOXYPROPYL) -5,5-DIMETHYLBENZOMETHYL PHARMACEUTICALLY IMPORTANT DERIVATIVES OF BENZOMORPHANIC COMPOUNDS AND METHODS FOR THE PREPARATION OF NORBENZOMORPHANO, 9,9-TRIMETHYL-6,7-BENZOMORPHAN
JPH04266875A (en) Novel imidazole compound, preparation thereof and medicinal composition containing the compound
IE67166B1 (en) New phenylethanolamino- and phenylethanolaminomethyltetralines process for the preparation thereof inermediates in said process and pharmaceutical compositions containing them
US3914232A (en) 2-And 4-acryloxy-N-substituted-morphinan derivatives
US3810899A (en) 2-hydroxy-n-substituted-morphinan derivatives
JP2009173672A (en) Use of compound in nucleophilic substitution reaction
JPH04506210A (en) Novel spirofuran derivative
AU608768B2 (en) Aryloxycycloalkanolamines
US3948919A (en) 2-Hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl)pyridine preparation and intermediate compounds
CA2042443A1 (en) Tricyclic compounds
US3914234A (en) 2-Lower alkoxy-N-substituted-morphinan derivatives
US3366688A (en) Process for the preparation of alpha, alpha-disubstituted-gema-hydroxyamines
GB2204584A (en) Cyclobutenediones useful as intermediates
US4760145A (en) Certain 6,7-methylene dioxydihydro or tetrahydro-isoquinoline derivatives
JPS60214789A (en) 2-azaerythrinan derivative
JPS6127393B2 (en)